GL1X · GenesisL1 explorer

Research workbench

Crystal structure of NE0047 (E143D) mutant in complex with 8- azaguanine

Analyse Crystal structure of NE0047 (E143D) mutant in complex with 8- azaguanine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7C3S
Type
protein
Length
370 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytidine and deoxycytidylate deaminase zinc-binding region
UniProt
Q82Y41
Ligands
AZG, ZN
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytidine and deoxycytidylate deaminase zinc-binding regionprotein18840% helix, 19% strandQ82Y41
BCytidine and deoxycytidylate deaminase zinc-binding regionprotein18242% helix, 20% strandQ82Y41

Ligands and binding sites

  • AZG · 5-amino-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol · ligand · chains B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12230.570.7933EDO
21520.560.8133AZG
3610.330.7721empty

Interfaces

1 interface between chains.

  • A–B · 1889 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 7C3S · Crystal structure of NE0047 (E143D) mutant in complex with 8-azaguanine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.